Activation of ras requires the ERM-dependent link of actin to the plasma membrane

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Sperka, Tobias ^a   Geißler, Katja J ^a   Merkel, Ulrike ^a   Scholl, Ingmar ^a   Rubio, Ignacio ^b   Herrlich, Peter ^a   Morrison, Helen L ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ERM PROTEIN; EZRIN; F ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; MOESIN; PROTEIN TYROSINE KINASE; RADIXIN; RAS PROTEIN; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; SOS PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; FUSED HETEROCYCLIC RINGS; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LATRUNCULIN B; MEMBRANE PROTEIN; MUTANT PROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; THIAZOLIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CATALYSIS; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; ANIMAL; BIOCATALYSIS; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; DRUG EFFECT; METABOLISM; MOUSE; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ACTINS; ALLOSTERIC SITE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BIOCATALYSIS; CELL LINE; CELL MEMBRANE; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; HUMANS; MEMBRANE PROTEINS; MICE; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS; RAS PROTEINS; RATS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; SON OF SEVENLESS PROTEINS; THIAZOLIDINES;

EID: 81455125472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027511     Document Type: Article

References (43)

1. Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, et al. (2008) Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Biol 15: 452-461.
2. Gureasko J, Kuchment O, Makino DL, Sondermann H, Bar-Sagi D, et al. (2010) Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless. Proc Natl Acad Sci U S A 107: 3430-3435.
3. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, et al. (1993) Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363: 85-88.
4. Kholodenko BN, Hancock JF, Kolch W, (2010) Signalling ballet in space and time. Nat Rev Mol Cell Biol 11: 414-426.
5. Bundschu K, Walter U, Schuh K, (2007) Getting a first clue about SPRED functions. Bioessays 29: 897-907.
6. Raabe T, Rapp UR, (2002) KSR-a regulator and scaffold protein of the MAPK pathway. Sci STKE 2002: PE28.
7. Ponta H, Sherman L, Herrlich PA, (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45.
8. Trusolino L, Bertotti A, Comoglio PM, (2001) A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654.
9. Klominek J, Baskin B, Hauzenberger D, (1998) Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction. Clin Exp Metastasis 16: 529-539.
10. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H, (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16: 3074-3086.
11. Sherman L, Wainwright D, Ponta H, Herrlich P, (1998) A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 12: 1058-1071.
12. Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, et al. (2007) Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67: 520-527.
13. Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, et al. (2007) Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell 18: 76-83.
14. Saleh HS, Merkel U, Geissler KJ, Sperka T, Sechi A, et al. (2009) Properties of an ezrin mutant defective in F-actin binding. J Mol Biol 385: 1015-1031.
15. Legg JW, Isacke CM, (1998) Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor CD44. Curr Biol 8: 705-708.
16. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, et al. (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15: 968-980.
17. McKernan RM, Quirk K, Jackson RG, Ragan CI, (1990) Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes. J Neurochem 54: 924-930.
18. Sheetz MJ, Tager HS, (1988) Characterization of a glucagon receptor-linked protease from canine hepatic plasma membranes. Partial purification, kinetic analysis, and determination of sites for hormone processing. J Biol Chem 263: 19210-19217.
19. Vetrivel KS, Cheng H, Kim SH, Chen Y, Barnes NY, et al. (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem 280: 25892-25900.
20. Pearson MA, Reczek D, Bretscher A, Karplus PA, (2000) Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259-270.
21. Block C, Janknecht R, Herrmann C, Nassar N, Wittinghofer A, (1996) Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo. Nat Struct Biol 3: 244-251.
22. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, et al. (1995) The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 375: 554-560.
23. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, et al. (2004) Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119: 393-405.
24. Rubio I, Wetzker R, (2000) A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins. Curr Biol 10: 1225-1228.
25. Yadav KK, Bar-Sagi D, (2010) Allosteric gating of Son of sevenless activity by the histone domain. Proc Natl Acad Sci U S A 107: 3436-3440.
26. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D, (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9: 706-712.
27. Grimsley CM, Lu M, Haney LB, Kinchen JM, Ravichandran KS, (2006) Characterization of a novel interaction between ELMO1 and ERM proteins. J Biol Chem 281: 5928-5937.
28. Lee JH, Katakai T, Hara T, Gonda H, Sugai M, et al. (2004) Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol 167: 327-337.
29. Takahashi K, Sasaki T, Mammoto A, Hotta I, Takaishi K, et al. (1998) Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene 16: 3279-3284.
30. Miralles F, Posern G, Zaromytidou AI, Treisman R, (2003) Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113: 329-342.
31. Treisman R, Alberts AS, Sahai E, (1998) Regulation of SRF activity by Rho family GTPases. Cold Spring Harb Symp Quant Biol 63: 643-651.
32. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, et al. (1995) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. Embo J 14: 951-962.
33. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
34. Cichowski K, Jacks T, (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593-604.
35. Lemmon MA, Schlessinger J, (2010) Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
36. Abiatari I, Esposito I, De Oliveira T, Felix K, Xin H, et al. (2010) Moesin dependent cytoskeleton remodeling is associated with an anaplastic phenotype of pancreatic cancer. J Cell Mol Med 14: 1166-1179.
37. Hunter KW, (2004) Ezrin, a key component in tumor metastasis. Trends Mol Med 10: 201-204.
38. Valastyan S, Benaich N, Chang A, Reinhardt F, Weinberg RA, (2009) Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev 23: 2592-2597.
39. Giordano S, Bardelli A, Zhen Z, Menard S, Ponzetto C, et al. (1997) A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc Natl Acad Sci U S A 94: 13868-13872.
40. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
41. Tomozawa Y, Sueoka N, (1978) In vitro segregation of different cell lines with neuronal and glial properties from a stem cell line of rat neurotumor RT4. Proc Natl Acad Sci USA 75: 6305-6309.
42. Porfiri E, Evans T, Chardin P, Hancock JF, (1994) Prenylation of Ras proteins is required for efficient hSOS1-promoted guanine nucleotide exchange. J Biol Chem 269: 22672-22677.
43. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, et al. (2003) Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112: 685-695.